Actively Recruiting

Age: 18Years +
All Genders
ID05821894

Carotid Plaque Imaging Project (Identification of Vulnerable Atherosclerotic Plaques With Imaging and Biological Markers)

Led by Lund University · Updated on 2024-10-15

3500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

L

Lund University

Lead Sponsor

R

Region Skane

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to better understand atherosclerotic plaques, which can rupture or erode and lead to heart attacks and strokes. The study focuses on identifying vulnerable plaques (VP) that are prone to causing these events. Researchers are investigating plaque structure using imaging techniques, circulating markers, and the underlying disease mechanisms to find new ways to detect and possibly treat these dangerous plaques early. Participants in this observational study are patients undergoing carotid endarterectomy, a procedure to remove plaques from carotid arteries. The study involves detailed analysis of the removed plaques to reveal their structure and mechanisms. Researchers also use imaging methods and circulating markers to study plaque characteristics and work on developing new detection approaches. During the study, participants will be monitored for post-operative cardiovascular events through follow-up assessments planned for the years 2025, 2027, and 2029. The study tracks the occurrence of events since previous follow-ups to evaluate the risk associated with vulnerable plaques. Participation includes providing informed consent and undergoing standard surgical procedures with additional research assessments related to plaque analysis and imaging.

CONDITIONS

Brief Title

Carotid Plaque Imaging Project (CPIP)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients older than 18 years old
  • Male or female patients eligible for carotid endarterectomy due to atherosclerosis
  • Ability to provide informed consent
Not Eligible

You will not qualify if you...

  • Patients younger than 18 years old
  • Inability to provide informed consent
  • Pregnant patients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 6 years

Participants are monitored over several years to record cardiovascular events after carotid endarterectomy.

Follow-up assessments in years 2025, 2027, and 2029

Trial Site Locations

Total: 1 location

1

Skåne University Hospital (SUS)

Malmö, Skåne County, Sweden, 214 28

Actively Recruiting

Loading map...

Research Team

I

Isabel Goncalves, MD, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Two-Center, Randomized, Double-Blind, Placebo-Controlled, ...

Atherosclerosis

Actively Recruiting

2 locations

A Phase IIa Multicenter Randomized Double-blind Placebo-cont...

Atherosclerosis

Actively Recruiting

6 locations

Acute Exposure to Diesel: Prolonged Effects on Inflammation ...

Atherosclerosis

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here